{"entity":{"type":"insider","cik":"0001765987","url":"/insider/0001765987","json_url":"/insider/0001765987.json","name":"Ostertag Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":16,"first":"2021-01-25","last":"2022-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Ostertag Eric","source":"filing","n_filings":16,"first_seen":"2021-01-25","last_seen":"2022-08-10"}],"transactions":[{"id":6398579,"accession":"0001209191-22-045296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045296","line_url":"/filing/0001209191-22-045296#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":142857.0,"shares_display":"142,857","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":499999.5,"total_display":"499,999.50","total_whole":"500,000","shares_owned_after":838824.0,"shares_owned_after_display":"838,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6252166,"accession":"0001209191-22-044562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044562","line_url":"/filing/0001209191-22-044562#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160696.0,"shares_display":"160,696","price_per_share":3.689,"price_display":"3.69","price_state":"stated","total_value":592807.544,"total_display":"592,807.54","total_whole":"592,808","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-05","scope":"insider"},{"id":5261197,"accession":"0001209191-21-063934","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-063934","line_url":"/filing/0001209191-21-063934","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18924.0,"shares_display":"18,924","price_per_share":7.09,"price_display":"7.09","price_state":"stated","total_value":134171.16,"total_display":"134,171.16","total_whole":"134,171","shares_owned_after":3659503.0,"shares_owned_after_display":"3,659,503","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-10","scope":"insider","n_lines":2},{"id":4793580,"accession":"0001209191-21-059651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059651","line_url":"/filing/0001209191-21-059651","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20029.0,"shares_display":"20,029","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":140603.58,"total_display":"140,603.58","total_whole":"140,604","shares_owned_after":3669376.0,"shares_owned_after_display":"3,669,376","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider","n_lines":2},{"id":5500020,"accession":"0001209191-21-057289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057289","line_url":"/filing/0001209191-21-057289#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.001,"price_display":"8.00","price_state":"stated","total_value":160020.0,"total_display":"160,020.00","total_whole":"160,020","shares_owned_after":160696.0,"shares_owned_after_display":"160,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"},{"id":5112476,"accession":"0001209191-21-056246","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-056246","line_url":"/filing/0001209191-21-056246#line-3","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.1356,"price_display":"8.14","price_state":"stated","total_value":162712.0,"total_display":"162,712.00","total_whole":"162,712","shares_owned_after":180696.0,"shares_owned_after_display":"180,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider"},{"id":4427450,"accession":"0001209191-21-054797","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-054797","line_url":"/filing/0001209191-21-054797","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61262.0,"shares_display":"61,262","price_per_share":8.34,"price_display":"8.34","price_state":"stated","total_value":510925.08,"total_display":"510,925.08","total_whole":"510,925","shares_owned_after":3679826.0,"shares_owned_after_display":"3,679,826","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider","n_lines":2},{"id":4427440,"accession":"0001209191-21-054797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054797","line_url":"/filing/0001209191-21-054797","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51149.0,"shares_display":"51,149","price_per_share":8.46,"price_display":"8.46","price_state":"stated","total_value":432720.54,"total_display":"432,720.54","total_whole":"432,721","shares_owned_after":3711789.0,"shares_owned_after_display":"3,711,789","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider","n_lines":2},{"id":5381415,"accession":"0001209191-21-049673","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-049673","line_url":"/filing/0001209191-21-049673","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19936.0,"shares_display":"19,936","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":159288.64,"total_display":"159,288.64","total_whole":"159,289","shares_owned_after":3738475.0,"shares_owned_after_display":"3,738,475","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-04","scope":"insider","n_lines":2},{"id":5381413,"accession":"0001209191-21-049673","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-049673","line_url":"/filing/0001209191-21-049673","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13737.0,"shares_display":"13,737","price_per_share":8.13,"price_display":"8.13","price_state":"stated","total_value":111681.81,"total_display":"111,681.81","total_whole":"111,682","shares_owned_after":3748876.0,"shares_owned_after_display":"3,748,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider","n_lines":2},{"id":4669317,"accession":"0001209191-21-045591","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-045591","line_url":"/filing/0001209191-21-045591","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27542.0,"shares_display":"27,542","price_per_share":8.905446227579697,"price_display":"8.91","price_state":"stated","total_value":245273.8,"total_display":"245,273.80","total_whole":"245,274","shares_owned_after":3756043.0,"shares_owned_after_display":"3,756,043","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider","n_lines":4},{"id":4669301,"accession":"0001209191-21-045591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-045591","line_url":"/filing/0001209191-21-045591","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20563.0,"shares_display":"20,563","price_per_share":9.77,"price_display":"9.77","price_state":"stated","total_value":200900.51,"total_display":"200,900.51","total_whole":"200,901","shares_owned_after":3770413.0,"shares_owned_after_display":"3,770,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider","n_lines":2},{"id":5250934,"accession":"0001209191-21-037931","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-037931","line_url":"/filing/0001209191-21-037931","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40722.0,"shares_display":"40,722","price_per_share":8.34,"price_display":"8.34","price_state":"stated","total_value":339621.48,"total_display":"339,621.48","total_whole":"339,621","shares_owned_after":3781142.0,"shares_owned_after_display":"3,781,142","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-03","scope":"insider","n_lines":2},{"id":5250928,"accession":"0001209191-21-037931","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-037931","line_url":"/filing/0001209191-21-037931","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41194.0,"shares_display":"41,194","price_per_share":8.61,"price_display":"8.61","price_state":"stated","total_value":354680.34,"total_display":"354,680.34","total_whole":"354,680","shares_owned_after":3802388.0,"shares_owned_after_display":"3,802,388","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider","n_lines":2},{"id":4569757,"accession":"0001209191-21-030484","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-030484","line_url":"/filing/0001209191-21-030484","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35986.0,"shares_display":"35,986","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":303721.84,"total_display":"303,721.84","total_whole":"303,722","shares_owned_after":3823881.0,"shares_owned_after_display":"3,823,881","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-05","scope":"insider","n_lines":2},{"id":4569746,"accession":"0001209191-21-030484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-030484","line_url":"/filing/0001209191-21-030484","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18326.0,"shares_display":"18,326","price_per_share":9.01,"price_display":"9.01","price_state":"stated","total_value":165117.26,"total_display":"165,117.26","total_whole":"165,117","shares_owned_after":3842656.0,"shares_owned_after_display":"3,842,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider","n_lines":2},{"id":4423666,"accession":"0001209191-21-025503","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-025503","line_url":"/filing/0001209191-21-025503","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57819.0,"shares_display":"57,819","price_per_share":9.662364707103201,"price_display":"9.66","price_state":"stated","total_value":558668.265,"total_display":"558,668.26","total_whole":"558,668","shares_owned_after":3853834.0,"shares_owned_after_display":"3,853,834","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-05","scope":"insider","n_lines":4},{"id":4423650,"accession":"0001209191-21-025503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-025503","line_url":"/filing/0001209191-21-025503","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57181.0,"shares_display":"57,181","price_per_share":9.5544,"price_display":"9.55","price_state":"stated","total_value":546330.1464,"total_display":"546,330.15","total_whole":"546,330","shares_owned_after":3882383.0,"shares_owned_after_display":"3,882,383","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider","n_lines":2},{"id":4224115,"accession":"0001209191-21-017377","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-017377","line_url":"/filing/0001209191-21-017377","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57060.0,"shares_display":"57,060","price_per_share":11.539,"price_display":"11.54","price_state":"stated","total_value":658415.34,"total_display":"658,415.34","total_whole":"658,415","shares_owned_after":3912217.0,"shares_owned_after_display":"3,912,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider","n_lines":2},{"id":4224105,"accession":"0001209191-21-017377","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-017377","line_url":"/filing/0001209191-21-017377","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57940.0,"shares_display":"57,940","price_per_share":11.66803451846738,"price_display":"11.67","price_state":"stated","total_value":676045.92,"total_display":"676,045.92","total_whole":"676,046","shares_owned_after":3942515.0,"shares_owned_after_display":"3,942,515","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider","n_lines":4},{"id":4416311,"accession":"0001209191-21-011390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011390","line_url":"/filing/0001209191-21-011390#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133149.0,"shares_display":"133,149","price_per_share":10.0041,"price_display":"10.00","price_state":"stated","total_value":1332035.9109,"total_display":"1,332,035.91","total_whole":"1,332,036","shares_owned_after":200696.0,"shares_owned_after_display":"200,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":4222711,"accession":"0001209191-21-010208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-010208","line_url":"/filing/0001209191-21-010208#line-2","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12389.0,"shares_display":"12,389","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":123890.0,"total_display":"123,890.00","total_whole":"123,890","shares_owned_after":333845.0,"shares_owned_after_display":"333,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":5465495,"accession":"0001209191-21-005238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-005238","line_url":"/filing/0001209191-21-005238#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001765987","owner_name":"Ostertag Eric","owner_display_name":"Ostertag Eric","owner_url":"/insider/0001765987","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4462.0,"shares_display":"4,462","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":44620.0,"total_display":"44,620.00","total_whole":"44,620","shares_owned_after":346234.0,"shares_owned_after_display":"346,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-21","filed_date":"2021-01-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001661460","name":"Poseida Therapeutics, Inc.","url":"/issuer/0001661460","role":"Director, Officer (Executive Chairman), Ten percent owner","n_filings":16,"first_seen":"2021-01-25","last_seen":"2022-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001765987","retrieved_at":"2026-08-22T22:05:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}